Delivery Order SPE2DB20D1100-SPE2DB25FC2J4

Award Date 5/9/25
Potential Completion Date 6/2/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,943,752 units of the medication OFEV 150 MG CAPSULE 60S. The contract has a ceiling value of $8,590.58 and an ultimate completion date of May 7, 2025. This award is not associated with a set-aside program and represents an open competition contract. AmerisourceBergen Drug Corp, a for-profit organization headquartered in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,590.58, is for the delivery of 4,568,060,744 units of the prescription medication OFEV 150 MG CAPSULE 60S. The contract is a firm fixed-price delivery order with a completion date of May 19, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the prescription medication OFEV 150 MG CAPSULE 60S, with a ceiling value of $7,905.56 and a completion date of September 3, 2024. The contract is not a set-aside and is a firm-fixed price arrangement. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous federal contracts and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,630.28, is for the provision of OFEV 100 MG capsules. The contract has an ultimate completion date of May 2, 2025 and is a firm fixed-price contract. The contract is not associated with a set-aside program and is an open competition award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,590.58, is for the delivery of the pharmaceutical product OFEV 150 MG CAPSULE 60S. The contract is a firm fixed-price, non-set-aside arrangement with a performance period ending on May 19, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OFEV 100 MG CAPSULE 60S, a medication, with a ceiling value of $8,630.28 and a period of performance through May 29, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.58 delivery order contract is for the provision of 4567955864 OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period ending on May 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $16,378.86, is for the delivery of OFEV 100 MG CAPSULE 60S, a medication, and has a completion date of January 22, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $8,590.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,062,067 units of the medication OFEV 150 MG CAPSULE 60S, with a performance period extending through May 19, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $7,905.56 order is for the delivery of OFEV 150 mg capsules to support military treatment programs and facilities. The award has a completion date of March 8, 2024 and was issued on February 15, 2024. This delivery order is issued under a larger, single award indefinite delivery contract...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC2J4
    Delivery Order

This is a delivery order (SPE2DB20D1100|SPE2DB25FC2J4) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,590.58 firm-fixed-price contract is for the supply of 4,568,199,665 units of the prescription medication OFEV 150 MG CAPSULE 60S. The contract has an ultimate completion date of June 2, 2025 and was awarded on May 9, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (SPE2DX) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which provides global pharmaceutical support to military healthcare programs through December 2026. The contract does not have a set-aside designation, indicating open competition.

Generated 8/8/25, 9:53 AM